Effects of Tiantai No. 1 on relative neuropeptides of spontaneous aged dementia mice

Chinese Journal of Neuroscience

Volumn 20, Issue 2, 2004, Pages 167-170

  Wu, Zheng Zhi ^a   Li, Ming ^a   Li, Yao Fang ^a   Zhang, Yong Feng ^a  

^a Shenzhen Institute of Transfusion Medicine   (China)

Author keywords

Adrenocorticotrophic hormone; Arginine vaso pressing; Cerebra cortex; Hippocampus; Mouse; Neuropeptide; Somatostatin; Spontaneous aged dementia; Tiantai NO. 1

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; DIHYDROERGOTOXINE MESILATE; HERBACEOUS AGENT; NEUROPEPTIDE; SOMATOSTATIN; TIANTAI 1; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEMENTIA; HIPPOCAMPUS; MOUSE; NONHUMAN; RANDOMIZATION;

EID: 1842658966     PISSN: 10080872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gage FH, bjorklund A, Stenevi V, et al. Intrahippocampal septal grafts ameliorate learning impairments in aged rats[J]. Science, 1984,225:533-536.
2. Gage FH, Bjordlund A. Cholinergic spetal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine-sensitive mechaniasm[J]. J Neruosci, 1986,6: 2837-2847.
3. Wend GL, Markowska AL, Olton DS. Basal forebrain lesions and memory: alterations in nerurotensin, not acetylcholine, may cause dementia[J]. Behav Neurosci, 1989,103:765-769.
4. De Wied D, Jolles J. Neuropeptides derived from pro-opiocortin: Behavioral, physio-logical and neurochemical effects[J]. Psysiol Rev, 1982,62:976-1059.
5. Justino L, Welner SA, Tannenbaum GS, et al. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels[J]. Brain Res, 1997,761:127-134.
6. Kovacs GL, De Wied D. Peptidergic modulation of learning and memory processes[J]. Pharmocol Rev, 1994,46:269-291.
7. Hayashi M, Yamashita A, Shimizu K. Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased level of mRNAs during aging[J]. Brain Res, 1997,749: 289.
8. Rinidainen KJ, Riekkinen PJ, Jokkonen J, et al. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease[J]. Brain Res, 1987,402:103-108.
9. Reindainen KJ, Soininen H, Kinkkinen PJ. Neurotransmitter changes in Alzheimer's disease: Implications to diagnostics and therapy [J]. J Neurosci Res, 1990,27:576-586.
10. Rossor MN, Iversen LL. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease[J]. Br Med Bull, 1986,42:170-174.
11. Kowall NW, Beal MF. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in Alzheimer's disease[J]. Ann Neurol, 1988,23,105-114.
12. Armstroag DM, Benzing WC, Evans J, et al. Substance P and somatostatin coexist within neuritic plaques: Implications for the pathogenesis of Alzheimer's disease[J]. Neuroscience, 1989,31:663-671.